Skip to content

Clinical trials

Primary Myelofibrosis trials in the United States with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Status: Unknown status Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20082
20091
20151
20191
20202
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kartos Therapeutics, Inc.4
Ronald Hoffman2
Medical College of Wisconsin1
Milton S. Hershey Medical Center1
Northwestern University1
Suzhou Zelgen Biopharmaceuticals Co.,Ltd1
Telios Pharma, Inc.1
The Cleveland Clinic1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis13
Blast Crisis4
Leukemia, Lymphocytic, Chronic, B-Cell4
Leukemia, Myeloid, Accelerated Phase4
Leukemia, Myeloid, Chronic-Phase4
Multiple Myeloma4
Myeloproliferative Disorders4
Polycythemia Vera4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Burkitt Lymphoma3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.